Skip to Main Content
ADVERTISEMENT
SCROLL TO CONTINUE WITH CONTENT



Property Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes
Advertisement
Maturitas
Close
  • Home
  • Articles & Issues
    • Back
    • Articles In Press
    • Current Issue
    • List of Issues
  • Collections
    • Back
    • Editor's Choice
    • EMAS Documents
  • Virtual Special Issues 
  • Free CME 
  • For Authors
    • Back
    • About Open Access
    • Author Information
    • Permissions
    • New Content Alerts
    • Researcher Academy 
    • Submit a Manuscript 
  • Journal Info
    • Back
    • About the Journal
    • About Open Access
    • Abstracting/Indexing
    • Career Opportunities 
    • Contact Information
    • Editorial Board
    • Information for Advertisers 
    • Pricing
    • Reprints 
    • Supplement Guidelines
  • Links
  • Subscribe
  • More Periodicals
    • Back
    • Find a Periodical 
    • Go to Product Catalog 
Advanced searchSave search

Please enter a term before submitting your search.

Ok
  • Submit
  • Log in
  • Register
  • Log in
    • Submit
    • Log in
  • Subscribe
  • Claim
Skip menu
    x

    Filter:

    Filters applied

    • EMAS Position Statements and Clinical Guides
    • Breast cancerRemove Breast cancer filter
    Clear all

    Article Type

    • Research Article2
    • Review Article1

    Publication Date

    • Last Year1
    • Last 2 Years1
    • Last 5 Years1
    Please choose a date range between 2014 and 2022.

    Author

    • Ceausu, Iuliana3
    • Lambrinoudaki, Irene3
    • Rees, Margaret3
    • Depypere, Herman2
    • Mueck, Alfred2
    • Pérez-López, Faustino R2
    • Simoncini, Tommaso2
    • Stute, Petra2
    • van der Schouw, Yvonne T2
    • Armeni, Eleni1
    • Bretz, Silvia1
    • Desreux, Joelle1
    • Durmusoglu, Fatih1
    • Erel, C Tamer1
    • Erkkola, Risto1
    • Fistonic, Ivan1
    • Gambacciani, Marco1
    • Geukes, Marije1
    • Goulis, Dimitrios1
    • Hamoda, Haitham1
    • Hartley, Caiomhe1
    • Hirschberg, Angelica Lindén1
    • Meczekalski, Blazej1
    • Mendoza, Nicolas1
    • Schenck-Gustafsson, Karin1

    Journal

    • Maturitas3

    Keyword

    • Osteoporosis2
    • Adjuvant therapy1
    • Aromatase inhibitors1
    • Bisphosphonates1
    • Cardiovascular disease1
    • Climacteric1
    • Denosumab1
    • Fractures1
    • Hormone replacement therapy1
    • Hot flushes1
    • Individualized1
    • Mammography screening1
    • Menopause1
    • Night sweats1
    • Screening1
    • Women1

    Access Filter

    • Open Access

    EMAS Position Statements and Clincial Guides

    3 Results
    Subscribe to collection
    • Export
      • PDF
      • Citation

    Please select at least one article in order to proceed.

    Ok
    FilterHide Filter
    • EMAS Consensus Statement

      Menopause, wellbeing and health: A care pathway from the European Menopause and Andropause Society

      Maturitas
      Vol. 163p1–14Published online: May 12, 2022
      • Irene Lambrinoudaki
      • Eleni Armeni
      • Dimitrios Goulis
      • Silvia Bretz
      • Iuliana Ceausu
      • Fatih Durmusoglu
      • and others
      Cited in Scopus: 10
      • Preview Hide Preview
      • Download PDF
      • Export Citation
        Life expectancy has considerably increased since 1970 [1], and now >50% of women are expected to break the 90-year barrier by 2030 [2]. Growing older rather than old means spending almost half of life after the menopause, challenging the concept of healthy ageing [3]. Iatrogenic menopause may be induced by cancer treatment or bilateral salpingo-oophorectomy for benign disease and may occur before the average age of natural menopause, which is around the age of 50 [4,5]. The sudden fall in estrogen levels with iatrogenic menopause may lead to rapid onset of vasomotor symptoms [4].
        Menopause, wellbeing and health: A care pathway from the European Menopause and Andropause Society
      • Review article

        Osteoporosis management in patients with breast cancer: EMAS position statement

        Maturitas
        Vol. 95p65–71Published online: October 6, 2016
        • Florence A. Trémollieres
        • Iuliana Ceausu
        • Herman Depypere
        • Irene Lambrinoudaki
        • Alfred Mueck
        • Faustino R. Pérez-López
        • and others
        Cited in Scopus: 33
        • Preview Hide Preview
        • Download PDF
        • Export Citation
          Breast cancer remains the most frequent cancer in women and its incidence is increasing. However, the mortality rate has stabilized due to the progress made in the treatment of breast cancer over the last decade. In premenopausal women with hormone receptor-positive breast cancer, the goal of adjuvant treatment is to inhibit the impact of estrogen on the breast, either by blocking the estrogen receptors (with the use of tamoxifen) or by suppressing ovarian function (through surgical oophorectomy or treatment with luteinizing hormone-releasing hormone (LHRH) agonist).
        • Research Article

          EMAS position statement: Individualized breast cancer screening versus population-based mammography screening programmes

          Maturitas
          Vol. 79Issue 4p481–486Published online: September 14, 2014
          • Herman Depypere
          • Joelle Desreux
          • Faustino R. Pérez-López
          • Iuliana Ceausu
          • C. Tamer Erel
          • Irene Lambrinoudaki
          • and others
          Cited in Scopus: 19
          • Preview Hide Preview
          • Download PDF
          • Export Citation
            Breast cancer originates from the malignant transformation of epithelial cells within the ducts and lobules of the breast. A malignant cell is the result of the accumulation of consecutive mutations. Up or down regulation of different mutated genes will ultimately result in the heterogeneity of breast cancers [1]. Some tumors will remain in situ and will never threaten the health of women. Other tumors will become invasive and ultimately metastasize and hence be fatal when not treated. The doubling time of tumor cells is estimated between 150 and 200 days [2].
            EMAS position statement: Individualized breast cancer screening versus population-based mammography screening programmes
          Page 1 of 1

          Login to your account

          Show
          Forgot password?
          Don’t have an account?
          Create a Free Account

          If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password

          If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password

          Cancel
          • Home
          • Articles & Issues
          • Articles In Press
          • Current Issue
          • List of Issues
          • Collections
          • Editor's Choice
          • EMAS Documents
          • Virtual Special Issues
          • Free CME
          • For Authors
          • About Open Access
          • Author Information
          • Permissions
          • New Content Alerts
          • Researcher Academy
          • Submit a Manuscript
          • Journal Info
          • About the Journal
          • About Open Access
          • Abstracting/Indexing
          • Career Opportunities
          • Contact Information
          • Editorial Board
          • Information for Advertisers
          • Pricing
          • Reprints
          • Supplement Guidelines
          • Links
          • Subscribe
          • More Periodicals
          • Find a Periodical
          • Go to Product Catalog

          The content on this site is intended for healthcare professionals.



          We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
          Copyright © 2023 Elsevier Inc. except certain content provided by third parties.

          • Privacy Policy  
          • Terms and Conditions  
          • Accessibility  
          • Help & Contact

          RELX